Delivery Order SPE2DP26D0001-SPE2DP26F1088
- Not listed
- The U.S. Office of the Assistant Secretary for Administration awarded a $418,637.55 firm-fixed-price purchase order to Meridian Medical Technologies, LLC for DuoDote auto-injectors (FPAE NDC #11704-0620-01) with an ultimate completion date of January 5, 2026. The contract was designated as a Total Small Business set-aside, with performance to be executed in St. Louis, Missouri. Meridian Medical Technologies is a wholly-owned subsidiary of Pfizer Inc. specializing in the development and...
- This federal contract award to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc., is for the development and delivery of an FDA-approved advanced autoinjector system (AAS). The definitive contract, valued at $41,936,532.62, is a cost-plus-incentive arrangement with the U.S. Department of Defense's Joint Program Executive Office for Chemical and Biological Defense. The award does not utilize a small business set-aside. Meridian, a manufacturer of medical countermeasures...
- This $17,955,751.55 firm fixed-price delivery order was awarded to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc., by the Department of State Bureau of Medical Services. The contract is for the provision of autoinjectors and associated training devices to be delivered globally to Department of State personnel through September 2028 under the Department's "MANDRAKE 3.0 IDIQ" contract. This single-award IDIQ contract vehicle has a total potential value of...
- This is a firm-fixed-price purchase order contract awarded by the U.S. Secret Service to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc., for the purchase of DuoDote auto-injector packs. The contract has a ceiling value of $70,111.80 and a completion date of May 5, 2018. Meridian Medical Technologies has a history of providing medical training devices, auto-injector kits, and nerve agent antidote treatments to various federal agencies, including the Department of...
- Meridian Medical Technologies, LLC was awarded a purchase order contract valued at $2,461 by the Defense Logistics Agency Troop Support Medical. The contract is for the delivery of a training device for nerve agent antidotes by December 27, 2023. No set-aside designation was used for this award. Meridian will provide one TRAINING DEVICE,DIA at its place of performance in Columbia, Maryland. Meridian is a manufacturer and provider of medical training services owned by Pfizer Inc., a large...
- This is a $660,839.00 firm fixed price definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Meridian Medical Technologies, LLC, a for-profit limited liability company that manufactures medical devices and provides medical training services. The contract has a completion date of February 15, 2019 and was awarded on August 1, 2018 without any set-aside designation. The contract was awarded under a Special...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Atropine 1 mg/mL vials under a firm fixed-price contract valued at $2,111.43. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Nithiodote 300 mg-12.5 gram 60mL with a ceiling value of $1,970.00 and a firm fixed price structure. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 7, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The U.S. Department of Defense's Medical Supply Chain awarded a $5,947.02 delivery order to AmerisourceBergen Drug Corp on April 10, 2025, for CYANOKIT 5 Gram VL 1S, a cyanide antidote auto-injector. This firm fixed-price delivery order, which must be completed by May 7, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is the prime contractor for this transaction. The...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,253.12 firm fixed-price delivery order is for the supply of ATROPINE 1 MG/ML VIALML, a critical medical product, with a completion date of February 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- SPE2DP26D0001Indefinite Delivery Contract
- SPE2DP26D0001-SPE2DP26F1088Delivery Order
The Defense Logistics Agency's Medical Supply Chain division awarded a $16.41M firm-fixed-price delivery order to Meridian Medical Technologies, LLC for antidote treatment products, with performance extending through September 9, 2026. Meridian, a wholly-owned Pfizer subsidiary based in St. Louis, Missouri, specializes in manufacturing medical countermeasures and autoinjector devices, particularly DuoDote autoinjectors containing atropine and pralidoxime chloride for treating nerve agent exposure. This delivery order was issued without a small business set-aside designation, reflecting Meridian's established position as a large contractor in the federal medical countermeasures marketplace. Meridian maintains a substantial federal contracting footprint across multiple agencies responsible for national preparedness and chemical-biological defense, including the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response, the Department of State, and the U.S. Marshals Service. The company currently operates under two primary indefinite delivery vehicles: the MANDRAKE 3.0 IDIQ contract with the Department of State ($100M ceiling, five-year term through September 2025) and an Other Transaction IDV with the Department of Defense's Joint Program Executive Office for Chemical and Biological Defense ($1M ceiling). Recent significant awards include a $129.7M firm-fixed-price contract from HHS ASPR in September 2024 for supplying DuoDote autoinjectors to the Strategic National Stockpile.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 12/8/25 | |
| Not listed | Not listed | $16.4m | 12/7/25 |